摘要
Background: KRAS mutation, one of the most important biological processes in colorectal cancer, leads to poor prognosis in patients. Although studies on KRAS have concentrated for a long time, there are currently no ideal drugs against KRAS mutations.Methods: Different expression analysis and weighted gene coexpression network analysis was conducted to select candidate genes. Log-rank tests and Cox regression picked out the prognostic genes to build a KRAS-related gene prognostic score (KRGPS). A nomogram based on KRGPS was built to predict survival of clinical patients. Comprehensive analysis showed the prognosis, immune microenvironment and response to immune therapy and chemotherapy in KRGPS subgroups.Results: We collected a KRGPS from the set of two genes GJB6 and NTNG1, with low-KRGSP patients having better progression-free survival (PFS). Low KRGPS is correlated with high infiltration of activated NK cells, plasma cells and activated memory CD4 T cells and that these cells benefit more from immune checkpoint inhibitor therapy. However, high KRGPS is associated with high infiltration of activated mast cells, pathways of immune dysregulation and a high ratio of TP53 and KRAS mutations. KRGPS subgroups are also sensitive to chemotherapy differently. A nomogram, established based on the KRGPS and pathological stage, predict 3- and 5-years PFS well.Conclusions: The KRAS-associated score acts as a promising signature to distinguish prognosis, molecular and immune characteristics, and benefits from immune and chemical therapy. These KRAS-associated genes could be promising targets for drug design.
学科与关键词
- Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancerLi, Yan; Li, Yiyi; Xia, Zijin; Zhang, Dun; Chen, Xiaomei; Wang, Xinyu; Liao, Jing; Yi, Wei*; Chen, Jun*Aging-US, 2021, 13(23): 25518-25549.被引 2
- KRAS modulates immune infiltration levels and survival outcomes in patients with lung adenocarcinomaLi, Na; Tian, Yue; Liu, Xin; Pan, Ciming; Xue, Jian*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(52): e36597.
- Identification and Validation of a Novel Prognostic Gene Model for Colorectal CancerMeng, Yan; Zhou, Rulin; Lin, Zhizhao; Peng, Qun; Ding, Jian; Huang, Mei; Li, Yiwen; Guo, Xuxue; Zhuang, Kangmin*Computational and Mathematical Methods in Medicine, 2022, 2022: 9774219.被引 1
